4536 SANTEN PHARMACEUTICAL CO.,LTD.参天製薬TSE Prime / Pharmaceuticals
0 posts
SANTEN PHARMACEUTICAL CO.,LTD. (4536) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
SANTEN PHARMACEUTICAL CO.,LTD. (4536) Stock Price History
SANTEN PHARMACEUTICAL CO.,LTD. closed at ¥2,002 on Nov 20, 2026, +15.9% over 1 month, +26.7% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥115,890 today (+15.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved +15.9%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,002 | −55.5 | −2.70% |
| Nov 19 (Thu) | ¥2,058 | +1.5 | +0.07% |
| Nov 18 (Wed) | ¥2,056 | −7 | −0.34% |
| Nov 17 (Tue) | ¥2,063 | −22.5 | −1.08% |
| Nov 16 (Mon) | ¥2,086 | +50.5 | +2.48% |
| Nov 13 (Fri) | ¥2,035 | +33.5 | +1.67% |
| Nov 12 (Thu) | ¥2,002 | +7 | +0.35% |
| Nov 11 (Wed) | ¥1,995 | −23 | −1.14% |
| Nov 10 (Tue) | ¥2,018 | −3 | −0.15% |
| Nov 9 (Mon) | ¥2,021 | +126.5 | +6.68% |
If you had invested ¥100,000 3 months ago, it would be worth ¥102,693 today (+2.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved +2.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,002 | −55.5 | −2.70% |
| Nov 19 (Thu) | ¥2,058 | +1.5 | +0.07% |
| Nov 18 (Wed) | ¥2,056 | −7 | −0.34% |
| Nov 17 (Tue) | ¥2,063 | −22.5 | −1.08% |
| Nov 16 (Mon) | ¥2,086 | +50.5 | +2.48% |
| Nov 13 (Fri) | ¥2,035 | +33.5 | +1.67% |
| Nov 12 (Thu) | ¥2,002 | +7 | +0.35% |
| Nov 11 (Wed) | ¥1,995 | −23 | −1.14% |
| Nov 10 (Tue) | ¥2,018 | −3 | −0.15% |
| Nov 9 (Mon) | ¥2,021 | +126.5 | +6.68% |
If you had invested ¥100,000 6 months ago, it would be worth ¥105,230 today (+5.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved +5.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,002 | +11.9% |
| Oct 2026 | ¥1,790 | +6.1% |
| Sep 2026 | ¥1,687 | −10.1% |
| Aug 2026 | ¥1,876 | −0.5% |
| Jul 2026 | ¥1,884 | −11.7% |
| Jun 2026 | ¥2,133 | +11.4% |
| May 2026 | ¥1,916 | +18.5% |
If you had invested ¥100,000 1 year ago, it would be worth ¥126,669 today (+26.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +26.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,002 | +11.9% |
| Oct 2026 | ¥1,790 | +6.1% |
| Sep 2026 | ¥1,687 | −10.1% |
| Aug 2026 | ¥1,876 | −0.5% |
| Jul 2026 | ¥1,884 | −11.7% |
| Jun 2026 | ¥2,133 | +11.4% |
| May 2026 | ¥1,916 | +18.5% |
| Apr 2026 | ¥1,616 | −9.5% |
| Mar 2026 | ¥1,786 | +2.1% |
| Feb 2026 | ¥1,749 | +0.6% |
| Jan 2026 | ¥1,738 | +6.9% |
| Dec 2025 | ¥1,626 | +1.7% |
| Nov 2025 | ¥1,600 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥146,828 today (+46.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +46.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,002 | +23.1% |
| 2025 | ¥1,626 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥128,829 today (+28.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +28.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,002 | +23.1% |
| 2025 | ¥1,626 | ― |
If you had invested ¥100,000 in Feb 2001, it would be worth ¥465,581 today (+365.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +334.1%, while this stock moved +365.6%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,002 | +23.1% |
| 2025 | ¥1,626 | +0.5% |
| 2024 | ¥1,619 | +15.2% |
| 2023 | ¥1,405 | +30.8% |
| 2022 | ¥1,074 | −23.7% |
| 2021 | ¥1,407 | −16.0% |
| 2020 | ¥1,675 | −19.7% |
| 2019 | ¥2,086 | +31.5% |
| 2018 | ¥1,586 | −10.4% |
| 2017 | ¥1,771 | +23.8% |
| 2016 | ¥1,430 | −28.7% |
| 2015 | ¥2,006 | +55.0% |
| 2014 | ¥1,294 | +31.9% |
| 2013 | ¥981 | +48.9% |
| 2012 | ¥659 | +4.3% |
| 2011 | ¥632 | +11.8% |
| 2010 | ¥565 | −4.0% |
| 2009 | ¥589 | +8.7% |
| 2008 | ¥542 | −1.3% |
| 2007 | ¥549 | −18.1% |
| 2006 | ¥670 | +5.0% |
| 2005 | ¥638 | +42.4% |
| 2004 | ¥448 | +57.6% |
| 2003 | ¥284 | +29.4% |
| 2002 | ¥220 | −26.3% |
| 2001 | ¥298 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2001). Please check the latest prices before trading.
SANTEN PHARMACEUTICAL CO.,LTD. (4536) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of SANTEN PHARMACEUTICAL CO.,LTD. (4536)
Business overview
Together with 33 consolidated subsidiaries and one equity-method affiliate, the company runs a pharmaceutical business centered on R&D, manufacturing and sales of pharmaceuticals as a single segment. For prescription drugs, the Japan business is handled by the company and 「参天アイケア」, while the China business, Asia business (South Korea, Taiwan, India, Thailand, the Philippines, Malaysia, Vietnam and others), EMEA (Europe, the Middle East and Africa) business and other businesses (North America and others) are handled by local subsidiaries. It offers over-the-counter drugs in Japan and Asia, and medical devices in Japan, EMEA and elsewhere.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 2.10% | No. 30 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 15.7x | Below the sector median of 16.5x (No. 16 from the lowest) |
| PBR | 2.12x | Above the sector median of 1.86x (No. 45 from the lowest) |
| ROE | 13.49% | No. 7 in the sector (highest first); median 4.17% |
| Market cap | ¥644.2 bn | No. 11 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥2,236 | 7/6 |
|---|---|---|
| 52-week low | ¥1,551 | 2025/12/5 |
| Current position | 65.8% | Where the low is 0% and the high is 100% (close on 11/20: ¥2,002) |
| Year to date | +23.1% | No. 9 of 77 in the sector (best first) |
| 1 year | +26.7% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/05 15:302027年3月期 第2四半期(中間期)決算短信〔IFRS〕(連結)
- 11/05 15:30自己株式取得に係る事項の決定に関するお知らせ
- 10/27 11:00主要株主の異動に関するお知らせ
- 10/16 16:00当社連結子会社の破産手続開始申立てに関するお知らせ
- 09/30 16:00事後交付型業績連動株式報酬としての自己株式処分の払込完了に関するお知らせ
Filings from the past 12 months (5).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the SANTEN PHARMACEUTICAL CO.,LTD. board
More Japanese stocks in English
- Fuso Pharmaceutical Industries,Ltd.4538
- NIPPON CHEMIPHAR CO.,LTD.4539
- iShares 20+ Year US Treasury Bond Premium Income ETF453A
- TSUMURA & CO.4540
- TERUMO CORPORATION4543
- H.U. Group Holdings,Inc.4544
- KISSEI PHARMACEUTICAL CO.,LTD.4547
- SEIKAGAKU CORPORATION4548
- EIKEN CHEMICAL CO.,LTD.4549
- JCR Pharmaceuticals Co.,Ltd.4552
- TOWA PHARMACEUTICAL CO.,LTD.4553
- Fuji Pharma Co.,Ltd.4554